Skip to main content
. 2024 Feb 4;13(2):808–818. doi: 10.21037/tcr-23-1502

Table 2. Results for each group.

Efficacy NAC group (N=15) Adjuvant group (N=5) Consolidation group (N=14) Salvage group (N=5)
ORR (%) 86.7 60.0
Mean PFS (months) 21.5 24.1 26.9 13.9
Mean OS (months) 22.8 24.2 28.1 17.1
2-year OS rates (%) 66.0 80.0 92.9 0.0

NAC, neoadjuvant chemotherapy; ORR, objective response rate; PFS, progression-free survival; OS, overall survival.